StockWatch
·
Pharmaceuticals
Management Change6 Aug 2026, 07:51 pm

Albert David Ltd: Head-R&D Resigns Effective August 2026

AI Summary

Albert David Ltd has announced the resignation of Dr. Kuntal Ganguly, Head-R&D, effective August 5, 2026. The resignation is due to personal reasons. The company expressed its appreciation for his services and contributions during his tenure. Further details as required by SEBI LODR Regulations are provided in Annexure-A, and a copy of the resignation email from the HR Department is enclosed.

Key Highlights

  • Dr. Kuntal Ganguly, Head-R&D, has resigned from Albert David Ltd.
  • The resignation is effective from August 5, 2026.
  • The reason cited for resignation is personal.
  • The company acknowledged his contributions.